Federal Register / Vol. 80, No. 54 / Friday, March 20, 2015 / Notices 15013 

must be resolved through the Disputes 

clause. Any audits requested by the 

commercial supplier or licensor will be 

performed at supplier or licensor’s 

expense. 

This class deviation will apply to all 

new awards for GSA acquisitions for 

commercial supplies or services. 

Existing contracts will be required to 

incorporate the new terms whenever an 

option period is exercised or the 

contract is otherwise modified. 

This effort will reduce risk by 

uniformly addressing common 

unacceptable Commercial Supplier 

Agreement terms, facilitate efficiency 

and effectiveness in the contracting 

process by reducing the administrative 

burden for the Government and 

industry, and promote competition by 

reducing barriers to industry, 

particularly small businesses. 

Dated: March 17, 2015. 

Jeffrey A. Koses, 

Senior Procurement Executive, Office of 

Acquisition Policy, Office of Governmentwide Policy. 

[FR Doc. 2015–06422 Filed 3–19–15; 8:45 am] 

BILLING CODE 6820–61–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Submission for OMB Review; 30-Day 

Comment Request: The Genetic 

Testing Registry 

SUMMARY: Under the provisions of 

section 3507(a)(1)(D) of the Paperwork 

Reduction Act of 1995, the National 

Institutes of Health (NIH) has submitted 

to the Office of Management and Budget 

(OMB) a request for review and 

approval of the information collection 

listed below. This proposed information 

collection was previously published in 

the Federal Register on November 25, 

2014 (79 FR 70194), and allowed 60- 

days for public comment. No public 

comments were received. The purpose 

of this notice is to allow an additional 

30 days for public comment. The Office 

of the Director (OD), National Institutes 

of Health, may not conduct or sponsor, 

and the respondent is not required to 

respond to, an information collection 

that has been extended, revised, or 

implemented on or after October 1, 

1995, unless it displays a currently valid 

OMB control number. 

Direct Comments to OMB: Written 

comments and/or suggestions regarding 

the item(s) contained in this notice, 

especially regarding the estimated 

public burden and associated response 

time, should be directed to the: Office 

of Management and Budget, Office of 

Regulatory Affairs, OIRA_submission@

omb.eop.gov or by fax to 202–395–6974, 

Attention: NIH Desk Officer. 

DATES: Comment Due Date: Comments 

regarding this information collection are 

best assured of having their full effect if 

received within 30-days of the date of 

this publication. 

FOR FURTHER INFORMATION CONTACT: To 

obtain a copy of the data collection 

plans and instruments or request more 

information on the proposed project 

contact: Ms. Sarah Carr, Acting Director, 

Office of Clinical Research and 

Bioethics Policy, Office of Science 

Policy, NIH, 6705 Rockledge Dr., Suite 

750, Bethesda, MD 20892, or call nontoll-free number (301) 496–9838, or 

Email your request, including your 

address to: OCRBP-OSP@od.nih.gov. 

Formal requests for additional plans and 

instruments must be requested in 

writing. 

Proposed Collection: The Genetic 

Testing Registry, 0925–0651, 

Reinstatment Without Change,—Office 

of the Director (OD), National Institutes 

of Health (NIH) 

Need and Use of Information 

Collection: Clinical laboratory tests are 

available for more than 5,000 genetic 

conditions. The Genetic Testing Registry 

(GTR) provides a centralized, online 

location for test developers, 

manufacturers, and researchers to 

voluntarily submit detailed information 

about the availability and scientific 

basis of their genetic tests. The GTR is 

of value to clinicians by providing 

information about the accuracy, 

validity, and usefulness of genetic tests. 

The GTR also highlights evidence gaps 

where additional research is needed. 

OMB approval is requested for 3 

years. There are no costs to respondents 

other than their time. The total 

estimated annualized burden hours are 

5,536. 

ESTIMATED ANNUALIZED BURDEN HOURS

Type of respondent Form name Number of 

respondents 

Number of 

responses per 

respondent 

Average 

burden per 

response 

(in hours) 

Total annual 

burden hours 

Laboratory Personnel Using Bulk 

Submission.

Minimal Fields .................................. 190 29 18/60 1,653 

Optional Fields ................................. 159 29 14/60 1,076 

Laboratory Personnel Not Using 

Bulk Submission.

Minimal Fields .................................. 116 29 30/60 1,682 

Optional Fields ................................. 97 29 24/60 1,125 

Dated: March 13, 2015. 

Lawrence A. Tabak, 

Deputy Director, National Institutes of Health. 

[FR Doc. 2015–06370 Filed 3–19–15; 8:45 am] 

BILLING CODE 4140–01–P 

mstockstill on DSK4VPTVN1PROD with NOTICES